default author photo

Jeanine Roodhart

Utrecht University - Oncode Institute

Utrecht

Netherlands

SCHOLARLY PAPERS

2

DOWNLOADS

85

TOTAL CITATIONS

3

Scholarly Papers (2)

1.

Drug Repurposing Screen on Patient-Derived Organoids Identifies New Therapeutic Drug Combination Against KRAS Mutant Colon Cancer

Number of pages: 42 Posted: 17 Mar 2021
Utrecht University - Oncode Institute, Utrecht University - Oncode Institute, Utrecht University - Oncode Institute, affiliation not provided to SSRN, Utrecht University - Oncode Institute, Utrecht University - Oncode Institute, Foundation Hubrecht Organoid Technology (HUB), Netherlands Cancer Institute - Mouse Clinic for Cancer and Aging (MCCA), Netherlands Cancer Institute - Mouse Clinic for Cancer and Aging (MCCA), Netherlands Cancer Institute - Mouse Clinic for Cancer and Aging (MCCA), University Medical Center (Utrecht) - Department of Medical Oncology, Foundation Hubrecht Organoid Technology (HUB), University Medical Center, Utrecht - Hubrecht Institute, Utrecht University - Oncode Institute, Utrecht University - Oncode Institute and Utrecht University - Oncode Institute
Downloads 44 (1,145,425)
Citation 3

Abstract:

Loading...

2.

Survival and Patient-Reported Outcomes of Real-World High-Risk Stage Ii and Stage Iii Colon Cancer Patients after Reduction of Adjuvant Capox Duration from 6 to 3 Months

Number of pages: 19 Posted: 17 May 2024
affiliation not provided to SSRN, affiliation not provided to SSRN, Netherlands Comprehensive Cancer Organisation, Utrecht University - Julius Center for Health Sciences and Primary Care, Utrecht University - University Medical Center (Utrecht), Utrecht University - University Medical Center (Utrecht) and Utrecht University - Oncode Institute
Downloads 41 (1,170,409)

Abstract:

Loading...

colon cancer, Adjuvant Chemotherapy, Survival, Patient Reported Outcome Measures, Quality of life, real-world data